GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jafron Biomedical Co Ltd (SZSE:300529) » Definitions » Other Operating Expense

Jafron Biomedical Co (SZSE:300529) Other Operating Expense : ¥412 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Jafron Biomedical Co Other Operating Expense?

Jafron Biomedical Co's Other Operating Expense for the three months ended in Mar. 2025 was ¥2 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥412 Mil.

Jafron Biomedical Co's quarterly Other Operating Expense increased from Sep. 2024 (¥-216 Mil) to Dec. 2024 (¥416 Mil) but then declined from Dec. 2024 (¥416 Mil) to Mar. 2025 (¥2 Mil).

Jafron Biomedical Co's annual Other Operating Expense declined from Dec. 2022 (¥410 Mil) to Dec. 2023 (¥344 Mil) but then increased from Dec. 2023 (¥344 Mil) to Dec. 2024 (¥399 Mil).


Jafron Biomedical Co Other Operating Expense Historical Data

The historical data trend for Jafron Biomedical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jafron Biomedical Co Other Operating Expense Chart

Jafron Biomedical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 248.56 342.34 410.01 344.38 399.08

Jafron Biomedical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.11 209.90 -215.82 416.10 1.63

Jafron Biomedical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥412 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jafron Biomedical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Jafron Biomedical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Jafron Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 98, Science and Technology 6th Road, High-tech Zone, Guangdong Province, Zhuhai, CHN, 519085
Jafron Biomedical Co Ltd is a China-based company engaged in the research, development, production, and sales of biomaterials and medical devices. It offers solutions for kidney disease, poisoning, rheumatic immune solution, critical illness and liver disease. The company's products include JFYC-100 pre-punching machine, DX-10 blood purifier, and HA resin hemoperfusion.
Executives
Li Feng Director
He Xiao Lian Executives
Dong Fan Directors, Directors, and Executives
Ceng Kai Directors, executives
Tang Xian Min Directors, executives
Zhang Ming Yuan Secretary Dong
Fang Li Hua Supervisors
Zhang Guang Hai Directors, executives
Li De Zhi Executives
Lu Shao Zhang Executives

Jafron Biomedical Co Headlines

No Headlines